A closer examination of the APOL1 gene in Black patients with kidney disease can provide more accurate diagnoses than current protocols, a new study from researchers at Columbia University Vagelos College of Physicians and Surgeons has found. Accurate diagnosis is important as treatments for kidney disease depend on the disease’s root causes and will take on more importance when treatments in development for APOL1 kidney disease become available.
This article was originally published on MedicalXpress.com
